Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FCO2 Chemoimmunotherapy in Young Patients With CLL
NCT01762202Phase 2Completed
- Sponsor
- GIMEMA
- Start
- Nov 2013
- Primary completion
- Nov 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab in chronic lymphocytic leukemia (CLL), sponsored by GIMEMA. Started Nov 2013; status: completed.
02
Drugs
ofatumumab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01762202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01762202.